Ultragenyx Pharmaceutical Inc. (RARE)
NASDAQ·Healthcare·Biotechnology
$25.97
+3.76%
Mkt Cap $2.56B
Analyst Ratings
Buy
0
Hold
1
Sell
0
Price Target (46 analysts)
$46.80
Range $30.00 – $67.00
Implied Upside
+80.2%
Consensus $46.80 vs current $25.97
NASDAQ·Healthcare·Biotechnology
$25.97
+3.76%
Mkt Cap $2.56B
Buy
0
Hold
1
Sell
0
Price Target (46 analysts)
$46.80
Range $30.00 – $67.00
+80.2%
Consensus $46.80 vs current $25.97